Erika Carmel-Tech Ltd (TLV:ERKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 52.10
+2.00 (3.99%)
May 20, 2026, 5:24 PM IDT
Erika Carmel-Tech Revenue
In the year 2025, Erika Carmel-Tech had annual revenue of 37.34M ILS, down -1.64%. Erika Carmel-Tech had revenue of 16.57M in the half year ending December 31, 2025, with 20.25% growth.
Revenue
37.34M
Revenue Growth
-1.64%
P/S Ratio
0.58
Revenue / Employee
829.78K
Employees
45
Market Cap
21.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.34M | -621.00K | -1.64% |
| Dec 31, 2024 | 37.96M | 8.08M | 27.03% |
| Dec 31, 2023 | 29.88M | -20.44M | -40.62% |
| Dec 31, 2022 | 50.32M | -46.53M | -48.04% |
| Dec 31, 2021 | 96.86M | 11.08M | 12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 54.78B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 177.50M |
| Bio-View | 19.93M |
| Evogene | 12.28M |
| Identi Healthcare | 10.93M |
| XTL Biopharmaceuticals | 3.26M |